• SENSEX 80,710.76
    -7.25 (--0.01%)
  • BANKNIFTY 54,114.55
    39.10 (+0.07%)
  • N S D L
    1,298.70 1,425.00(%)
  • Ola Electric
    59.38 39.58(%)
  • Netweb Technol.
    3,180.10 3,180.10(%)
  • Indus Towers
    341.75 444.45(%)
  • Vodafone Idea
    7.45 15.22(%)
  • Moschip Tech.
    258.25 279.00(%)
  • Godfrey Phillips
    11,150.00 11,462.00(%)
  • Vimta Labs
    902.85 902.85(%)
  • G M D C
    515.00 515.00(%)
  • Fiem Industries
    2,005.00 1,156.00(%)
  • One Mobikwik
    309.00 698.30(%)
  • Brainbees Solut.
    407.80 734.25(%)
  • Apollo Micro Sys
    298.65 88.10(%)
  • Avantel
    180.20 191.01(%)
  • Swiggy
    440.00 617.00(%)
  • TCS
    3,029.50 2,992.05(%)
  • Eternal Ltd
    334.40 334.40(%)
  • L&T Finance Ltd
    232.85 232.85(%)
  • Reliance Industr
    1,380.80 1,551.00(%)
  • Kross Ltd
    235.00 271.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kabra Drugs Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 2908.0
  • ISIN : INE323K01017
18.35 1 (4.50%)
  • As on 06 Sep 2025 (EOD)

  • Today’s Low

    17.10

  • Today’s High

    18.43

  • Open

    17.90

  • Perv Close

    17.56

  • 52W Low

    9.14

  • 52W High

    22.77

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    43.50

  • Div & Yield %

    0.00

  • Book Value(₹)

    10.40

  • Debt-Equity Ratio

    4.50

  • AGM Date

    05-Sep-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    43.50

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    23.71

  • BV (₹)

    10.40

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -1.09

  • NP Var(%)

    -47.0

  • Div%

    0.0

  • CPS (₹)

    -0.50

  • EPS (₹)

    -0.50

  • Traded Value (₹ in Lakhs)

    43.50

  • 52 Week High

    22.77

  • 52 Week Low

    9.14

  • Price BSE

    18.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    43.50

  • P/C Ratio

    -39.60

  • P/E Ratio

    -39.30

  • Price Vs.BV

    -0.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.01 0.00 0.00 0.02 0.01
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 0.00 0.01 0.00 0.00 0.02 0.01
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.40 0.23 0.09 0.05 0.00 0.03
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Selling and Administration Expenses 0.30 0.09 0.08 0.10 0.05 0.10
Miscellaneous Expenses 0.04 0.02 0.01 0.00 0.00 0.00
Employee Benefit Expenses 0.40 0.23 0.09 0.05 0.00 0.03
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 0.74 0.34 0.18 0.15 0.05 0.14
Operating Profit -0.74 -0.34 -0.18 -0.15 -0.03 -0.12
Interest 0.00 0.00 0.00 0.00 0.00 0.01
Gross Profit -0.74 -0.34 -0.18 -0.15 -0.03 -0.13
Depreciation 0.00 0.00 0.01 0.03 0.03 0.03
Profit Before Tax -0.74 -0.34 -0.19 -0.18 -0.06 -0.16
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -0.74 -0.34 -0.19 -0.18 -0.06 -0.16
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -0.74 -0.34 -0.19 -0.18 -0.06 -0.16
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -5.12 -4.78 -4.60 -4.42 -4.36 -4.19
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -5.86 -5.12 -4.78 -4.60 -4.42 -4.36
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.68 -0.77 -0.42 -0.41 -0.14 0.00
Earnings Per Share(Adj)-Unit Curr -1.68 -0.77 -0.42 - -0.14 0.00
Book Value -3.34 -1.67 -0.90 -0.47 -0.06 0.07
Book Value(Adj)-Unit Curr -3.34 -1.67 -0.90 - -0.06 0.07

Shareholding Pattern

  • Public Share Holding

    100.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 321,291 1.36 234,991 34
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 8,600 0.04 8,600 6
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 20,026,106 84.47 20,000,906 177
Individuals holding nominal share capital up to Rs. 1 lakh 2,640,944 11.14 1,319,343 7,173
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 710,909 3.00 710,709 59
Sub Total 23,707,850 100.00 22,274,549 7,449
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 23,707,850 100.00 22,274,549 7,449

Company Background

Kabra Drugs LtdPharmaceuticals - Indian - Formulations

  • Kabra Drugs Ltd
  • BSE Code : 2908.0
  • ISIN : INE323K01017

  • Incorporation Year

    1989

  • Registered Office

    270 Shastri Market Indore
    , Indore,
    Madhya Pradesh-452007

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    N Aravind

  • Company Secretary

    Monika Sanwal

  • Auditor

    Rishi Sekhri & Associates/PPN and Company

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Ankit Consultancy Pvt Ltd
    Plot No. 60,
    Electronic Complex,Pardeshipura
    Mumbai - Indore - 452010

Kabra Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kabra Drugs 18.35 0.00 0.00 -41.70 0.00
Abbott India 31,179.05 6,684.73 6,409.15 45.62 44.95
Astrazeneca Phar 9,088.15 1,756.92 1,716.29 123.92 32.94
P & G Health Ltd 6,465.40 944.52 934.17 35.70 40.23
Glaxosmi. Pharma 2,770.30 3,866.05 3,723.49 49.82 58.72
Cipla 1,553.30 20,029.57 19,044.85 23.21 21.40
Amrutanjan Healt 769.30 469.50 451.82 40.79 21.89
Guj. Themis Bio. 383.80 152.47 150.80 93.84 27.21
Fermenta Biotec. 334.60 442.21 430.53 11.10 17.61
Bliss GVS Pharma 156.00 703.42 667.20 23.32 9.16
Ambalal Sarabhai 32.39 19.33 4.04 16.96 2.10